MDMA: A review of epidemiological data

Journal of Psychoactive Drugs

Volumn 34, Issue 2, 2002, Pages 163-169

  Landry, Mim J ^a  

^a Danya International Inc   (United States)

Author keywords

Epidemiology; MDMA; Statistics; Trends

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS;

ADDICTION; ANIMAL; HUMAN; PSYCHOLOGICAL ASPECT; REVIEW; CONFERENCE PAPER; DEATH; DRUG ABUSE; DRUG OVERDOSE; EMERGENCY WARD; EPIDEMIOLOGY; MONITORING; PERCEPTION; PREVALENCE; STATISTICS;

ANIMALS; HUMANS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; SUBSTANCE-RELATED DISORDERS;

EID: 0036324580     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2002.10399950     Document Type: Article

References (19)

1. Centers for Disease Control and Prevention. 1998. What We Have Learned From the AIDS Evaluation of Street Outreach Projects: A Summary Document. Atlanta, Georgia: Centers for Disease Control and Prevention.
2. Hibell, B.; Andersson, B.; Ahlstrom, S.; Balakireva, O.; Bjamason T.; Kokkevi, A. & Morgan, M. 2000. The 1999 ESPAD Report: Alcohol and Other Drug Use Among Students in 30 European Countries. Stockholm, Sweden: Swedish Council for Information on Alcohol and Other Drugs, and The Pompidou Group at the Council of Europe.
3. Johnston, L.D.; O'Malley, P.M. & Bachman, J.G. 2002. Monitoring the Future: National Results on Adolescent Drug Use. Overview of Key Findings, 2001. Bethesda, Maryland: National Institute on Drug Abuse.
4. Johnston, L.D.; O'Malley, P.M. & Bachman, J.G. 2001a. Monitoring the Future: National Survey Results on Drug Use, 1975-2000. Volume 1: Secondary School Students. Bethesda, Maryland: National Institute on Drug Abuse.
5. Johnston, L.D.; O'Malley, P.M. & Bachman, J.G. 2001b. Monitoring the Future: National Survey Results on Drug Use, 1975-2000. Volume 11: College Students and Young Adults Ages 19-40. Bethesda, Maryland: National Institute on Drug Abuse.
6. National Center on Addiction and Substance Abuse at Columbia University. 2001. CASA National Survey of American Attitudes on Substance Abuse VI: Teens. New York: National Center on Addiction and Substance Abuse at Columbia University.
7. National Institute on Drug Abuse. 2001a. Epidemiologic Trends in Drug Abuse: Volume 1: Highlights and Executive Summary. December 2000. Bethesda, Maryland: Division of Epidemiology, Services, and Prevention Research, National Institute on Drug Abuse.
8. National Institute on Drug Abuse. 2001 b. Epidemiological Trends in Drug Abuse Advance Report, June 2001. Rockville, Maryland: National Institute on Drug Abuse, Community Epidemiology Work Group.
9. Partnership for a Drug-Free America. 2000. Partnership Altitude Tracking Study: Spring 2000: Teens in Grades Seven Through Twelve. New York: Partnership for a Drug-Free America.
10. Shulgin, A.T. 1978. Psychomimetic drugs: Structure-activity relationships. In: L.L. Iverson; S.D. Iverson & S.H. Snyder (Eds.) Handbook of Psychopharmacology. New York: Plenum Press.
11. Substance Abuse and Mental Health Services Administration. 2001a. Year-End 2000 Emergency Department Data from the Drug Abuse Warning Network. DAWN Series D-18. Rockville, Maryland: SubstanceAbuseand Mental Health Services Administration, Office of Applied Studies.
12. Substance Abuse and Mental Health Services Administration. 2001b. Summary of Findings from the 2000 National Household Survey on Drug Abuse. Rockville, Maryland: Office of Applied Studies, Substance Abuse and Mental Health Services Administration.
13. Substance Abuse and Mental Health Services Administration. 2000. The DAWN Report. Rockville, Maryland: Office of Applied Studies, Substance Abuse and Mental Health Services Administration, December.
14. United Nations. 2000. World Drug Report 2000. Oxford, England: United Nations Office for Drug Control and Crime Prevention.
15. United States Customs Service. 2001. Ecstasy News. Washington, D.C., May 16, 2001.
16. United States Drug Enforcement Administration. 2001a. Drug Trafficking in the United States. Washington, D.C.: United States Drug Enforcement Administration.
17. United States Drug Enforcement Administration. 2001b. DEA Congressional Testimony. Testimony presented to the Senate Caucus on International Narcotics Control. Washington D.C., March 21.
18. United States Drug Enforcement Administration. 2000. DEA Congressional Testimony. Testimony presented to the Senate Caucus on International Narcotics Control. Washington D.C., July 25.
19. United States rug Enforcement Administration. 1999. Drug Intelligence Brief: MDMA—Ecstasy. Washington, D.C.: United States Drug Enforcement Administration.